Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS Diagnosis
Rapid HIV antibody assays for detecting recent seroconversion modified
October 23rd, 2005
Scientists have modified rapid human immunodeficiency virus (HIV) antibody assay protocols for detecting recent HIV seroconversion. According to recent research from the United States, "Assay protocols of three rapid human immunodeficiency virus (HIV) assays, OraQuick-1/2, SeroStrip-1/2, and Determine-1/2, were modified to detect recent HIV seroconversion using a higher dilution of serum specimens. Optimal predilution of specimens resulted in negative test results during early periods of seroconversion (about 6 months), when antibody levels were low." "A total of 269 seropositive specimens from routine HIV type 1 testing and from commercial sources...
Source: Medical Letter on the CDC & FDA (2005-10-23)
|
